advertisement
Archiv der Pharmazie 10
Showing records 1 to 10 | Display all abstracts in Archiv der Pharmazie106279 Tail approach synthesis of triazolylthiazolotriazole bearing benzenesulfonamides as carbonic anhydrase inhibitors capable of inducing apoptosis
Vats L
Archiv der Pharmazie 2023; 356: e2200439
105861 Phthalimide-tethered imidazolium salts: Synthesis, characterization, enzyme inhibitory properties, and in silico studies
Yiğit M
Archiv der Pharmazie 2022; 355: e2200348
106279 Tail approach synthesis of triazolylthiazolotriazole bearing benzenesulfonamides as carbonic anhydrase inhibitors capable of inducing apoptosis
Siwach K
Archiv der Pharmazie 2023; 356: e2200439
105861 Phthalimide-tethered imidazolium salts: Synthesis, characterization, enzyme inhibitory properties, and in silico studies
Demir Y; Barut Celepci D
Archiv der Pharmazie 2022; 355: e2200348
106279 Tail approach synthesis of triazolylthiazolotriazole bearing benzenesulfonamides as carbonic anhydrase inhibitors capable of inducing apoptosis
Angeli A; Bikal P
Archiv der Pharmazie 2023; 356: e2200439
105861 Phthalimide-tethered imidazolium salts: Synthesis, characterization, enzyme inhibitory properties, and in silico studies
Taskin-Tok T; Arınç A
Archiv der Pharmazie 2022; 355: e2200348
106279 Tail approach synthesis of triazolylthiazolotriazole bearing benzenesulfonamides as carbonic anhydrase inhibitors capable of inducing apoptosis
Bhardwaj JK; Supuran CT
Archiv der Pharmazie 2023; 356: e2200439
105861 Phthalimide-tethered imidazolium salts: Synthesis, characterization, enzyme inhibitory properties, and in silico studies
Yiğit B; Aygün M
Archiv der Pharmazie 2022; 355: e2200348
106279 Tail approach synthesis of triazolylthiazolotriazole bearing benzenesulfonamides as carbonic anhydrase inhibitors capable of inducing apoptosis
Sharma PK
Archiv der Pharmazie 2023; 356: e2200439
105861 Phthalimide-tethered imidazolium salts: Synthesis, characterization, enzyme inhibitory properties, and in silico studies
Özdemir İ; Özdemir İ; Gülçin İ
Archiv der Pharmazie 2022; 355: e2200348
